Veridex’s GeneSearch BLN First FDA-OKed Gene Dx to Detect Metastatic Breast Cancer

The assay, the first FDA-approved test of its kind to detect whether breast cancer has spread to sentinel lymph nodes, is much faster than standard pathology techniques, though it was found to yield slightly more false positive results than intra-operative microscopic examination.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.